Categories AlphaGraphs, Earnings, Health Care

AbbVie Q4 2024 adjusted earnings decline despite 6% revenue growth

Biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) announced fourth-quarter 2024 financial results, reporting a double-digit dip in adjusted earnings and an increase in revenues.

AbbVie Q4 2024 earnings infographic

The company reported worldwide net revenues of $15.1 billion for the December quarter, up 6% from the corresponding period of 2023. The main operating segments registered growth.

Net income, adjusted for special items, declined to $2.16 per share in Q4 from $2.79 per share in the year-ago quarter. On a reported basis, it was a net loss of $22 million or $0.02 per share in the fourth quarter, compared to a profit of $822 million or $0.46 per share last year.

Prior Performance

  • AbbVie Q2 2024 earnings infographic
  • AbbVie Q1 2024 earnings infographic
  • AbbVie Q4 2023 earnings infographic

Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.

Most Popular

Important takeaways from Conagra Brands’ Q3 2025 report

Conagra Brands, Inc. (NYSE: CAG) has reported weaker-than-expected revenue and profit for the February quarter, with sales declining across all business segments amid softer demand and persistent supply challenges. The

Main takeaways from Lamb Weston’s (LW) Q3 2025 earnings report

Shares of Lamb Weston Holdings, Inc. (NYSE: LW) jumped 9% on Thursday after the company delivered better-than-expected results for the third quarter of 2025 and reaffirmed its outlook for the

Summary: Tesla (TSLA) reports Q1 2025 production, deliveries

Tesla Inc. (NASDAQ: TSLA) has announced results of vehicle production and deliveries for the first quarter of 2025. The company also provided data on the deployment of energy storage products

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close